EGFR and neoplasm: Our first hypothesis is sustained in previous evidences suggesting that the frequency of receptors heterodimers in tumor lines is lower for those expressing higher levels HER1 or HER2, since the equilibrium is displaced toward homodimerization of the overexpressed partner [30].